Coronavirus Disease 2019 (COVID-19) Impact on the Pharmaceutical Industry in 2020

Coronavirus Disease 2019 (COVID-19) Impact on the Pharmaceutical Industry in 2020

Summary

The highly contagious SARS-CoV-2 virus, which causes coronavirus disease 2019 (COVID-19), emerged at the close of 2019 and has led to a medical crisis across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020.

The pandemic has now killed over 2.1 million people worldwide. This sobering milestone comes just one year after the first death was reported on January 11, 2020 in China. The virus has spread to 195 countries, with more than 99 million confirmed cases.

The virus has significantly impacted the global economy and employment rates. All industries have been affected in some way, with some such as travel, tourism, and hospitality decimated.

This report provides an overview of the impact of COVID-19 across the pharmaceutical industry in 2020.

This report assesses the impact of COVID-19 across the pharmaceutical industry in 2020 and includes information from existing publications as well as additional data and analysis from the Pharmaceutical Intelligence Center.
Scope

The report includes the following areas -

  • Drug development
  • Clinical trials and regulation
  • Supply chain
  • Business development and licensing
  • Financial performance
  • Sales and marketing
  • Emerging technologies
Reasons to Buy
  • Get a comprehensive overview of the impact of COVID-19 on different sectors of the pharmaceutical industry with analysis from GlobalData’s core datasets, surveys, and polls.
  • See how emerging technologies have played a key role during the pandemic.
  • See how the pandemic will continue to shape the industry in 2021.


  • Executive Summary
  • Introduction
    • COVID-19 and the Pharmaceutical Value Chain
    • Pharmaceutical COVID-19 Mitigation Strategies
  • Drug Development
    • Drug Development Overview
    • COVID-19 Vaccine and Therapeutics Winners and Losers
    • The COVID-19 Vaccine and Therapeutic Pipeline Is Crowded
    • Clinical Investigations of Novel and Existing Drugs Continue to Grow
    • Most COVID-19 Clinical Trials Are Ongoing in the US
    • COVID-19 Related Deal-Making Trends
    • Examples of COVID-19 Pharma Partnerships
    • Examples of Public and Private Partnerships
    • Operation Warp Speed
    • Approved and Authorized Vaccines and Therapies for COVID-19
    • Promising Vaccines in Development
    • COVID-19 Vaccines Global Analyst Consensus Sales Forecast
    • Promising Therapies in Development
    • Therapeutic Drugs Global Analyst Consensus Sales Forecast
    • Majority of Industry Expected a Vaccine to be Approved and Available Within a Year
    • mRNA Vaccines Seen as the Most Promising Technology
    • Positive Industry Outlook on Therapeutic Development
    • Most Respondents Believe COVID-19 Therapeutics Data Are Reliable
    • Remdesivir Seen as the Most Promising Treatment…
  • Clinical Trial and Regulatory Delays
    • Regulatory and Clinical Trial Delays Overview
    • Regulatory and Clinical Trial Delays Winners and Losers
    • All Types of Organizations Have Reported Disruptions, with Phase II Trials Most Affected
    • Disruption of Clinical Trials Has Reduced but Levels Are Still High
    • Trial Activity Has Started to Resume After a Period of Disruption
    • Companies Currently Impacted by Trial Delays
      • Table Top 20 companies impacted by trial delays due to COVID-19
    • Survey Found that Clinical Trial Disruption Is the Primary Business Concern During the Pandemic
    • Inability or Delay to Initiate Clinical Trials Was the Highest Concern
    • Remote Patient Monitoring Is the Top Way Respondents Are Addressing Clinical Trial Disruptions
    • Use of Virtual Trials Was Moderate Before COVID-19
    • Post-Pandemic Decentralized Trials Use
    • Greater Participation of Patients and Sites in Clinical Trials Listed as the Biggest Benefits of DCTs
    • Almost Two-thirds of Respondents Expect DCTs to be used Frequently Within the Next 1–2 Years
    • Limited Regulatory Delays in 2020
    • About 25% of Industry Respondents Believed That Clinical Trial Disruption Would Last More Than One Year
    • COVID-19 Impact on Pharmaceutical Value Chain
  • Supply Chain
    • Supply Chain Overview
    • Pharmaceutical Supply Chains Around the World Were Impacted by COVID-19 But Disruptions Now Resolved
    • Survey Assessed Supply Chain Concerns Due to COVID-19 and Future Strategic Plans in Q1 and Q3 2020
    • Impact on Supply Chains Ranked One of the Top Business Concerns in Q1 and Q3
    • Supply Chain Concerns: Clinical Trial Materials
    • Supply Chain Concerns: Marketed Drugs
    • Supply Chain Concerns: Import/Export Risks
    • COVID-19 Planning Scenarios
    • Planning Scenarios: Manufacturing Sites
    • Planning Scenarios: Suppliers
  • Business Development & Licensing
    • Business Development & Licensing Overview
    • Overall Pharma Deal Activity Not Significantly Impacted by COVID-19 During 2020
    • M&A Activity Stayed High in 2020 Despite COVID-19, with Mega-Deals Boosting Value
    • Strategic Alliances Increased in 2020, Driven By COVID-19
    • COVID-19 Changed Focus of Contract Service Agreements to Infectious Disease in 2020
    • COVID-19 Vaccine Manufacturing Challenges Cause Surge in Outsourcing Deals in 2020
  • Financial Performance
    • Financial Performance Overview
    • Industry View on Impact of COVID-19 on Company Revenue
    • In Q1 2020, Companies Developing COVID-19 Drugs Had a Smaller Market Cap Decrease
    • In Q2 2020, Big Pharma Was Unscathed by COVID-19 as Market Caps Soared
    • However, Market Cap Fell for Half of Top 20 Companies in Q3 2020
    • Many Potentially Ineligible Companies Applied for Government Loans During the Pandemic in 2020
    • Numbers of Active Pharma Jobs Dropped Significantly in March 2020 but Recovered by November
  • Sales & Marketing
    • Sales & Marketing Overview
    • In 2020, Marketing and Sales Will Benefit Most from Digital Transformation
    • Increased Demand for Remote Marketing Platforms in 2020
    • Digital Display Advertising Spend Increased for Several Top Pharma Brands in April 2020
    • Pharma Companies Also Increased TV Ad Spend During the Pandemic with Several Releasing Tailored Messaging
  • Emerging Technology
    • Emerging Technology Overview
    • Several Emerging Technologies Were Identified in early 2020 as Having the Greatest Impact for Managing COVID-19
    • Telemedicine Was Flagged as an Important Technology Early in the Pandemic
    • Physicians Were Using Telemedicine Before COVID-19, but Not in Many Patients
    • Surveyed Physician Use of Telemedicine Increased During the Pandemic
    • Surveyed Physician Use of Telemedicine Expected to Remain High in the Future
    • Increased App Downloads for Leading Patient Telemedicine Platforms in Q2 2020
    • Increased Website Traffic for Leading Provider Telemedicine Platforms in Q2 2020
    • Increased Mobile App Downloads for Provider Telemedicine Platforms in Q2 2020
      • Table Most physician apps and patient companion apps had significant increases in downloads in Q2 2020
    • Remote Patient Monitoring Expected to Have Greatest Impact on the Pharmaceutical Industry in 2021
    • RPM Technologies are Viewed as the Future of Standard Care
    • Several Significant Events Occurred in the Digital Therapeutics Space in 2020
    • COVID-19 Could Be a Tipping Point for AI, Which Has the Potential to Transform Drug Discovery
    • Increasing Number of AI-Based Drug Discovery Partnerships with Big Pharma
    • Pfizer, Takeda, and AstraZeneca Lead the Way in AI Partnerships for Drug Discovery
    • Pharma Plans to Invest in AI in the Next Two Years
    • AI Recognized as a Leading Disruptive Technology in Pharma
  • 2021 Outlook
  • Appendix
    • Methodology
    • Abbreviations
    • Bibliography
    • Related Reports
    • About the Authors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook